Rep. Lisa C. McClain bought Novartis AG (NVS)
Rep. Lisa C. McClain (R-MI-9) · $1K–$15K · traded Sep 11, 2025
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Spouse
- Traded
- Sep 11, 2025
- Disclosed
- Oct 22, 2025
- Days to disclose
- 41
- Asset type
- Stock
- As filed
- Novartis AG Common Stock
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
All of McClain's trades →- Oct 22, 2025$1K–$15K
Sold Ryman Hospitality Properties RHP
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
Sold British American Tobacco p.l.c. BTI
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
Sold (partial) Amazon.com AMZN
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
Sold Boise Cascade Company BCC
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
Got $5K from the company’s PAC - Oct 22, 2025$1K–$15K
Bought Baxter International BAX
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
Committee overlap: Financial Services - Oct 22, 2025$1K–$15K
Sold Air Products and Chemicals APD
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
Recent Congress trades in NVS
- Sep 25, 2026$15K–$50K
Rep. Kevin Hern (R-OK-1)
$15K–$50K · Traded Aug 27, 2026 · disclosed Sep 25, 2026
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
Committee overlap: HELP - Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 30, 2026 · disclosed Jul 21, 2026 · filed 113 days later
Committee overlap: HELP - Nov 21, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 31, 2025 · disclosed Nov 21, 2025 · Spouse
- Nov 21, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 30, 2025 · disclosed Nov 21, 2025 · Spouse
- Nov 21, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 30, 2025 · disclosed Nov 21, 2025 · Spouse
- Oct 22, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
Sold (partial) Novartis AG NVS
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
Sold (partial) Novartis AG NVS
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
Company context for NVS
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
NVS: 6-K company filing
Filed 6-K for an event or period dated 2026-09-30. Read the company report for its disclosures.
Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
A Notice notice explicitly mentions the company. Read the cited text for its role.
Public: Sep 17, 2026Original source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.